DR.REDDY'S LABORATORIES LTD. - Dr. Reddys Laboratories Ltd. Receives FDA approval for ZEMBRACE"SymTouch" (sumatriptan succinate) Injection for the acute treatment of migraines in adults

Download	< Back
29 Jan 2016
Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated January 29, 2016 titled "Dr. Reddys Laboratories Ltd. Receives FDA approval for ZEMBRACE"SymTouch" (sumatriptan succinate) Injection for the acute treatment of migraines in adults".
View all announcements for DR.REDDY'S LABORATORIES LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us